VERTEX PHARMACEUTICALS INC / MA
VRTX
Latest Filing: May 5, 2026 • 25 Total Filings
Total Assets
2026
$26.48B
Total Revenue
2026
$2.99B
Net Income
2026
$1.03B
Operating Cash Flow
2026
$1.43B